Breaking News
November 16, 2018 - Eagle Books | Native Diabetes Wellness Program
November 16, 2018 - Patients with common heart failure more likely to have lethal heart rhythms
November 16, 2018 - How AI could help veterinarians code their notes | News Center
November 16, 2018 - Bias-based bullying does more harm to students than generalized bullying
November 16, 2018 - Researchers find first direct evidence that cerebellum plays role in cognitive functions
November 16, 2018 - Non-coding genetic variant plays key role in endothelial function and disease incidence
November 16, 2018 - EMA recommends first all-oral treatment to tackle deadly sleeping sickness
November 16, 2018 - Drug used to treat dizziness may slow down growth of triple-negative breast cancer
November 16, 2018 - AHA: Icosapent Ethyl Cuts CV Risk From Elevated Triglycerides
November 16, 2018 - ‘Orphan’ RNAs make cancer deadlier, but potentially easier to diagnose
November 16, 2018 - Air Cube touches down at hospital | News Center
November 16, 2018 - CRISPR-based tool shown to enhance cell-based immunotherapy
November 16, 2018 - Mechanisms that govern HIV latency differ in the gut and blood, finds study
November 16, 2018 - Researchers unravel mystery of NPM1 protein in acute myeloid leukemia
November 16, 2018 - High school students less likely to select milk, fruit for lunch when fruit juice is available
November 16, 2018 - Football coaches with great emotional competence are more successful
November 16, 2018 - Researchers awarded $10 million grant to address root causes of asthma in Puerto Rico
November 16, 2018 - Health Tip: Manage Morning Sickness
November 16, 2018 - Immunotherapy combination and chemotherapy show encouraging results in Phase II acute myeloid leukemia study
November 16, 2018 - ACC Latin America Conference brings experts to discuss latest cardiovascular science
November 16, 2018 - Pooled analysis of Intersect ENT’s steroid releasing implants in patients after frontal sinus surgery to be published
November 16, 2018 - Expectations about pain intensity can become self-fulfilling prophecies
November 16, 2018 - NIH awards $3.4 million to UC researchers to study gastrointestinal lymphatic system
November 16, 2018 - Scientist Dr David Taylor of MR Solutions is a finalist in the BMW i UK Tech Founder Awards
November 16, 2018 - Earlier treatment could help reverse autistic-like behavior in tuberous sclerosis
November 16, 2018 - Sucking your baby’s pacifier could improve their health
November 16, 2018 - Vegetables and salad may include bacteria that are resistant to antibiotics
November 16, 2018 - Autism linked to prolonged connection between brain regions
November 16, 2018 - Endocrine Society chooses four Diabetes Caucus leaders as winners of Diabetes Champion Award
November 16, 2018 - Brain and muscle cells found within kidney organoids
November 16, 2018 - Person’s sex hormones may play key role in trauma survival, finds study
November 16, 2018 - PTEN Genetic Test: MedlinePlus Lab Test Information
November 16, 2018 - Toxic metal pollution linked with development of autism spectrum disorder
November 16, 2018 - Calcified nodules in the retina increase risk for progression to late stages of AMD
November 16, 2018 - ZEISS teams up with arivis AG to offer complete 3D imaging solutions
November 16, 2018 - Georgia State professor receives $1.2 million grant to study how the brain controls eating behavior
November 16, 2018 - Specific bacterial toxins reduce number of cells suppressing immune response
November 16, 2018 - Review by ID physician improves outcomes for outpatient parenteral antimicrobial therapy
November 16, 2018 - Conditions that produce signs similar to arthritis
November 16, 2018 - New artificial intelligence-based method predicts treatment effectiveness
November 16, 2018 - AHA: Dapagliflozin Noninferior to Placebo for MACE in T2DM
November 16, 2018 - Surgery remains best treatment for appendicitis, Stanford study finds
November 16, 2018 - Non-surgical fistula creation system Ellipsys becomes key focus of attention at CiDA
November 16, 2018 - Researchers find no link between ‘allergy friendly’ dogs and lower risk of asthma
November 16, 2018 - Researchers elucidate new rules of connectivity of neurons in the neocortex
November 16, 2018 - Treating children with ‘bubble baby disease’
November 16, 2018 - Nexus announces availability of Arsenic Trioxide Injection in the US
November 16, 2018 - Researchers find metabolite shuttle between cells in the liver that may combat tissue fibrosis
November 16, 2018 - AHA: PTSD Common Among Those Who Suffer Tear in the Aorta’s Wall
November 16, 2018 - Many RA patients’ pain related to central nervous system
November 16, 2018 - Changes in Himalayan gut microbiomes linked to diet
November 16, 2018 - Inhibition of prostaglandin E2 enhances ability to combat infectious colitis
November 16, 2018 - Chronic dry eye can slow reading rate and disrupt day to day tasks
November 16, 2018 - Researchers develop new drug molecule that inhibits inflammation
November 16, 2018 - Dementia symptoms peak in winter and spring, study finds
November 16, 2018 - Stanford tobacco researcher weighs in on JUUL
November 16, 2018 - Increasing omega-3 fatty acid intake during pregnancy reduces risk of premature birth, review finds
November 16, 2018 - Researchers find no link between infants waking up at night and later developmental problems
November 16, 2018 - Both parents and children agree about confidential medical services
November 16, 2018 - FDA warns against use of unapproved pain medications with implanted pumps
November 16, 2018 - Precision medicine-based approach to slow or reverse biologic drivers of Alzheimer’s disease
November 16, 2018 - Study provides new insight into norovirus outbreaks, may help guide efforts to develop vaccines
November 16, 2018 - Inexpensive, portable air purifier could help protect the heart from pollution
November 16, 2018 - New 15-minute scan could help diagnose brain damage in babies up to two years old
November 16, 2018 - Deep brain stimulation not effective for treating early Alzheimer’s
November 16, 2018 - Traditional chemotherapy superior to new alternative for oropharyngeal cancers | News Center
November 16, 2018 - What This Pond Protist Does With Its Genome Will Astound You
November 15, 2018 - Researchers develop tool that speeds up analysis and publication of biomedical data
November 15, 2018 - Scientists identify mechanism used by lung cancer cells to obtain glucose
November 15, 2018 - Abnormalities in development of the brain could be involved in onset of autism, finds new study
November 15, 2018 - Soy protein equally effective as animal protein in building muscle strength
November 15, 2018 - American Academy of Pediatrics, Nov. 2-6
November 15, 2018 - Dopamine drives early addiction to heroin
November 15, 2018 - Variance in gut microbiome in Himalayan populations linked to dietary lifestyle | News Center
November 15, 2018 - Reducing Cardiovascular Disease: The Amish Way
November 15, 2018 - King’s researchers launch charter to guide organizations to engage abuse survivors in research
November 15, 2018 - Enable Injections enters into development agreements with UCB and Apellis Pharmaceuticals
November 15, 2018 - TGen North collaborates with NARBHA Institute to advance human health
November 15, 2018 - Researchers discover molecular basis for therapeutic actions of an African folk medicine
November 15, 2018 - Human Cell Atlas study of early pregnancy shows how mother’s immune system is modified
Understanding AFib: Slowing down the dancing heart

Understanding AFib: Slowing down the dancing heart

image_pdfDownload PDFimage_print

In atrial fibrillation (AFib), half of the heart’s four chambers aren’t beating properly, but are dancing around randomly without rhythm.

This sounds scary and, in some ways, it’s astonishing that people with AFib can function well at all. But remember that the heart’s upper chambers (the atria), which are malfunctioning in AFib, don’t pump blood to the body or through the lungs. They simply pass blood on to the muscular lower chambers of the heart (the ventricles) that do the hard work.

People with AFib tend to do fine when they’re not exerting themselves. Without treatment for AFib’s fast heart rate, however, the ability to be physically active is greatly reduced and the heart muscle can be damaged over time. As with all of us, AFib patients benefit from consistent, moderate exercise. Thus, slowing down the heart in AFib is a key goal.

Sometimes finding the right solution for AFib patients is like a puzzle.

When George H., our 71-year-old patient with AFib, was first diagnosed, his heart rate was 150 beats per minute (normal at rest is 60-100). With his heart rate this high, he felt that he could not do anything requiring even mild exertion.

During his first visit to the ER, he was given metoprolol, a beta blocker drug, to slow down his heart. When this dose did not consistently lower his heart rate below 100 beats per minute, his doctor doubled his dose.

George, however, often has a normal electrical pattern of regular heartbeat and only goes into AFib on occasion. When his heart is not in AFib and he took the doubled dose of metoprolol, his blood pressure fell to 105/55, his heart rate went down to 48, and he became “fuzzy-headed.” For George, finally switching to a dose halfway in between the low and high doses solved this problem.

For some people, AFib is an occasional problem, termed “paroxysmal AFib.”  When their hearts go into AFib they often go back to a normal rhythm on their own or can be given drugs or a mild electrical shock to return them to a normal heart rhythm. For others, AFib is permanent, meaning once their heart is in AFib, it stays in AFib.

For both groups, it is critical to keep the heart rate in a normal range. This makes people in AFib feel much better and allows them to be more active. It also protects the heart muscle from damage. Three types of inexpensive drugs are used to the lower heart rate in AFib:

  • Beta blockers, also used to lower blood pressure, are prescribed to 21 percent of AFib patients to reduce heart rate. They reduce the number of chaotic electrical signals from the heart’s upper chambers (the atria) that can travel into the lower ventricles where the signals trigger contraction of the muscular part of the heart. When using beta blockers, heart rate often goes down dramatically, for example, from 140 to 90 beats per minute. Commonly used beta blockers include metoprolol (brand name Toprol) and carvedilol (Coreg). Potential side effects include weight gain, cold hands or feet, and fatigue.
  • The calcium channel blockers verapamil and diltiazem are also used to lower heart rate in AFib. They work in a similar way to beta blockers. These drugs are taken by 10 percent of AFib patients and have side effects that include headache, constipation, and ankle swelling.
  • Digoxin, often used in the past to slow down the heart rate in AFib, is less effective and requires more monitoring than other drugs. Today only 3 percent of AFib patients use this drug.

The relatively low rate of use of these drugs implies that they may be underused. Some AFib patients not taking these heart-rate-lowering medications might benefit from their effectiveness in reducing AFib symptoms and improving quality of life.

A logical first step in the AFib journey is to understand the risk of stroke as well as the benefits and dangers of blood thinners. Knowing the drugs commonly used to slow down the heart in AFib is also important as you become more aware of AFib and how it is treated.

This is the fourth in a series of blog posts called Understanding AFib to help patients with atrial fibrillation live healthier lives. Next week, the blog post will discuss how patients can tell whether they are in AFib and how to measure their heart rate. George H. is an actual patient with some details altered to protect his confidentiality. Estimates related to drugs used for heart rate control come from IQVIA’s National Disease and Therapeutic Index.

Randall Stafford, MD, PhD, is a professor of medicine at Stanford and practices primary care internal medicine. Stafford and Stanford cardiologist Paul Wang, MD, lead an American Heart Association effort to improve stroke prevention decision-making in atrial fibrillation.

Photo by Max Pixel

Tagged with:

About author

Related Articles